Select Publications

Conference Posters

Chan C; Wacher M; Vaughan M; Grulich A; Fraser D; Philpot S; Bavinton B, 2022, 'Gay and bisexual men exposed to PrEP social marketing campaigns had higher awareness and knowledge of PrEP dosing regimens', Sunshine Coast, QLD, presented at Joint Australasian HIV&AIDS and Sexual Health Conferences, Sunshine Coast, QLD, 29 August 2022 - 01 September 2022

Storer D; Prestage G; Murphy D; Grulich A; Holt M; Ellard J; Bavinton B; Philpot S; Maher L; Jin F; Saxton P; Batrouney C; Hammoud M, 2021, 'Challenges of recommencing HIV pre-exposure prophylaxis (PrEP) use during the COVID-19 pandemic', Virtual, presented at IAS Conference on HIV Science 2021, Virtual, 18 July 2021

McManus H; Drak D; Heron JE; Vickers T; Vaccher S; Zablotska I; Guy RJ; Bavinton B; Jin F; Grulich AE; Bloch M; O'Connor CC; Gracey D, 2020, 'PrEP DRUG RESISTANCE AND RENAL IMPAIRMENT', presented at Conference on Retroviruses and Opportunistic Infections, 08 March 2020, https://www.croiconference.org/abstract/renal-impairment-in-a-preexposure-prophylaxis-implementation-cohort-in-australia/

Vaccher S; Holt M; Prestage G; Amin J; Selvey C; Zablotska-Manos I; Guy R; Jin F; Carr A; Grulich A; Bavinton B, 2019, 'Methamphetamine users in the EPIC-NSW study report high adherence to pre-exposure prophylaxis (PrEP)', Perth, Western Australia, presented at Australian HIV and AIDS Conference, Perth, Western Australia, 17 September 2019, https://az659834.vo.msecnd.net/eventsairaueprod/production-ashm-public/965b72bcb63f490083f4c0b91255431c

Vaccher S; Guy R; Templeton D; Zablotska-Manos I; Clackett S; Holt M; Prestage G; Amin J; Selvey C; Jin F; Grulich A; Bavinton B, 2019, 'Pre-exposure prophylaxis use among trans and gender diverse people: Characteristics and behaviour from the EPIC-NSW trial', Vancouver, Canada, presented at STI & HIV World Congress, Vancouver, Canada, 14 July 2019

Vaccher S; Grulich A; Haire B; Templeton D; McNulty A; Foster R; Ooi C; Poynten M; Prestage G; Zablotska-Manos I, 2018, 'High adherence to HIV PrEP among clinic attendees over 12 months in the PRELUDE open-label demonstration project', Canberra, Australia, presented at Australian HIV and AIDS Conference, Canberra, Australia, 06 November 2018

Vaccher S; Marzinke M; Grulich AE; Ooi C; Carr A; Haire BG; Selvey C; Templeton DJ; Holt M; Crooks L; Zablotska I, 2017, 'High adherence to HIV pre-exposure prophylaxis (PrEP) in participants presenting for month 12 visit in PRELUDEopen-label study in NSW, Australia', Paris, France, presented at International AIDS Society, Paris, France, 23 July 2017 - 26 July 2017, http://programme.ias2017.org/Abstract/Abstract/3358

Vaccher SJ; Grulich A; Prestage G; Bavinton B; Zablotska-Manos I, 2016, 'Use of behavioural eligibility criteria to identify high-HIV risk gay and bisexual men (GBM) for enrolment in a pre-exposure prophylaxis (PrEP) study in NSW, Australia', Durban, South Africa, presented at AIDS 2016, Durban, South Africa, 16 July 2016 - 21 July 2017

Vaccher S; Prestage G; McNulty A; Carr A; Holden J; Schmidt H-M; Holt M; Ooi C; Templeton D; Poynten M; Grulich A; Zablotska-Manos I, 2015, 'Characteristics of Gay Men in Sydney using HIV Pre-Exposure Prophylaxis (PrEP): Baseline Data from the PrELUDE Study', Brisbane, Australia, presented at Australian HIV and AIDS Conference, Brisbane, Australia, 16 September 2015

Yeung A; Caruana T; Grulich A; de Visser R; Rissel C; Simpson J; Richters J, 2015, 'P04.15 Sexual behaviour, sti testing and diagnosis down under: findings from the second australian study of health and relationships (ashr2)', Vol. 91, pp. A101.1 - A101, http://dx.doi.org/10.1136/sextrans-2015-052270.269

Templeton DJ; Fin F; Prestage G; Donovan BJ; Imrie JC; Kippax SC; Cunningham AL; Mindel A; Kaldor JM; Grulich AE, 2007, 'Circumcision status and risk of HIV and sexually transmitted infections in the HIM cohort of homosexual men in Sydney, Australia', Madrid, Spain, presented at 11th European AIDS Conference (EACS) 2008, Madrid, Spain, 24 October 2007 - 27 October 2007


Back to profile page